Moghtaderi A, Khosrawi S, Dehghan F: Extracorporeal shock wave therapy of gastroc-soleus trigger points in patients with plantar fasciitis: a randomized, placebo-controlled trial. Adv Biomed Res 3: 99, 2014.
Seligman DA, Dawson DR: Customized heel pads and soft orthotics to treat heel pain and plantar fasciitis. Arch Phys Med Rehabil 84: 1564, 2003.
Tallia AF, Cardone DA: Diagnostic and therapeutic injection of the ankle and foot. Am Fam Physician 68: 1356, 2003.
Zhu F, Johnson JE, Hirose CB, et al: Chronic plantar fasciitis: acute changes in the heel after extracorporeal high-energy shock wave therapy: observations at MR imaging. Radiology 234: 206, 2005.
Pascual Huerta J, Alarcón García JM: Effect of gender, age and anthropometric variables on plantar fascia thickness at different locations in asymptomatic subjects. Eur J Radiol 62: 449, 2007.
Kaplan S, Serbest MO, Çetin C, et al: Short and medium-term results of ESWT on heel pain caused by plantar fasciitis. J Med School 19: 37, 2012.
Park J-W, Yoon K, Chunk S, et al: Long-term outcome of low-energy extracorporeal shock wave therapy for plantar fasciitis: comparative analysis according to ultrasonographic findings. Ann Rehabil Med 38: 534, 2014.
Wang CJ, Wang FS, Yang KD, et al: Shock wave therapy induces neovascularization at the tendon bone junction. a study in rabbits. J Orthop Res 21: 984, 2003.
Othman AM, Ragab EM: Endoscopic plantar fasciotomy versus extracorporeal shock wave therapy for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg 130: 1343, 2010.
Kudo P, Dainty K, Clarfield M, et al: Randomized, placebo-controlled, double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracoporeal shock wave therapy (ESW T) device: a North American confirmatory study. J Orthop Res 24: 115, 2006.
Maki M, Ikoma K, Imai K, et al: Correlation between the outcome of extracorporeal shock wave therapy and pretreatment MRI findings for chronic plantar fasciitis. Mod Rheumatol 25: 427, 2015.
Ji HM, Kim HJ, Han SJ: Extracorporeal shock wave therapy in myofascial pain syndrome of upper trapezius. Ann Rehabil Med 36: 675, 2012.
Buchbinder R, Ptasznik R, Gordon J, et al: Ultrasound-guided extracorporeal shock wave therapy for plantar fasciitis: a randomized controlled Trial. JAMA 288: 1364, 2002.
Bannuru RR, Flavin NE, Vaysbrot E, et al: High-energy extracorporeal shock-wave therapy for treating chronic calcific tendinitis of the shoulder: a systematic review. Ann Intern Med 160: 542, 2014.
Lyon R, Liu XC, Kubin M, et al: Does extracorporeal shock wave therapy enhance healing of osteochondritis dissecans of the rabbit knee? a pilot study. Clin Orthop Relat Res 471: 1159, 2013.
Vural M, Biçer M, Ersoy S, et al: Evaluation of extracorporeal shock wave therapy effectiveness in plantar fasciitis. Med J Bakirkoy 2: 64, 2013.
Dizon JN, Gonzalez-Suarez C, Zamora MT, et al: Effectiveness of extracorporeal shock wave therapy in chronic plantar fasciitis: a meta-analysis. Am J Phys Med Rehabil 92: 606, 2013.
Tuna S: Efficiency of extracorporeal shock wave therapy in patients with plantar fasciitis and the relationship with subcalcaneal spur length. Dicle Med J 41: 337, 2014.
Resnick D: Diagnosis of Bone and Joint Disorders, 3rd Ed, WB Saunders, Philadelphia, 1995.
Notarnicola A, Moretti B: The biological effects of extracorporeal shock wave therapy (ESWT) on tendon tissue. Muscles Ligaments Tendons J 2: 33, 2012.
Liang HW, Wang TG, Chen WS, et al: Thinner plantar fascia predicts decreased pain after extracorporeal shock wave therapy. Clin Orthop Relat Res 460: 219, 2007.
Yalcin E, Keskin Akca A, Selcuk B, et al: Effects of extracorporal shock wave therapy on symptomatic heel spurs: a correlation between clinical outcome and radiologic changes. Rheumatol Int 32: 343, 2012.
Extracorporeal shockwave therapy (ESWT) has recently been used as a new treatment modality for plantar fasciitis. We aimed to determine the efficacy of ESWT by magnetic resonance imaging (MRI) findings.
Thirty patients with plantar fasciitis who had received no treatment for 6 months were included. Extracorporeal shockwave therapy was applied once a week for a total of three sessions (frequency of 12–15 Hz, 2–3 bars, and 2,500 pulses). All of the patients were assessed with the visual analog scale, a 6-point evaluation scale, the Foot and Ankle Outcome Score (FAOS), and MRI findings before and 3 months after ESWT. Visual analog scale scores were used in determining the pain level of patients in the morning, during activity, and at rest. Foot and ankle–related problems were evaluated with the FAOS.
The duration of painless walking according to the 6-point rating scale, the FAOS, and pain showed significant improvements after ESWT (P < .05). Significant decreases in MRI findings, including thickening of the plantar fascia, soft-tissue edema, and bone marrow edema, were observed after treatment (P < .05).
Extracorporeal shockwave therapy is a safe and effective treatment that yields favorable results in improvement of pain and function for plantar fasciitis. An MRI is useful for determining response to ESWT for these patients.